Efficacy and Safety of Intramuscular HBIG Grifols for the Prevention of Recurrence After Liver Transplantation
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if treatment with intramuscular hepatitis B virus
immune globulin Grifols, a new specific hepatitis B immune globulin, is effective and safe
for the prevention of hepatitis B virus recurrence after orthotopic liver transplantation.